Patients with Barrett's esophagus have 30-40 times higher risk of developing adenocarcinoma of distal esophagus. Treatment of Barrett's esophagus without dysplasia is identical with treatment of gastroesophageal reflux disease. (Tab. 1, Ref. 5.).